Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52
A
ACAD• CFO reduces stake in August transactions
ACADIA Pharmaceuticals CFO Mark C. Schneyer cut his stake to 67,828 shares in transactions dated Aug. 5-6.
AXSM
•
Acadia Pharmaceuticals CFO Mark C. Schneyer disposes of 25,141 common shares worth $730,047.52 - ACAD News | Rallies
